Concepedia

Bradley J. Herberich

BJ

Statistics

Publications

3

Citations

119

H-Index

3

Active since

2012

Affiliations

Amgen (United States)(Current)

Bradley J. Herberich is an author at Amgen (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2012–2016

3

Publications

3

Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511

Mark H. Norman, Kristin L. Andrews, Yunxin Bo et al. · Journal of Medicinal Chemistry · 2012 · 50 citations · Full text

, , +15

Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors

Liping H. Pettus, Kristin L. Andrews, Shon K. Booker et al. · Journal of Medicinal Chemistry · 2016 · 41 citations · Full text

, , +8

Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors

Victor J. Cee, Frank Chavez, Bradley J. Herberich et al. · ACS Medicinal Chemistry Letters · 2016 · 28 citations · Full text

, , +14

1–3 of 3